title: Myopic choroidal neovascularization.
authors.forename: Jose M
authors.initials: JM
authors.lastname: Ruiz-Moreno
authors.forename: María I
authors.initials: MI
authors.lastname: López-Gálvez
authors.forename: Juan
authors.initials: J
authors.lastname: Donate
authors.forename: Francisco
authors.initials: F
authors.lastname: Gomez-Ulla
authors.forename: José
authors.initials: J
authors.lastname: García-Arumí
authors.forename: Alfredo
authors.initials: A
authors.lastname: García-Layana
authors.forename: Inmaculada
authors.initials: I
authors.lastname: Sellés
authors.forename: Juan
authors.initials: J
authors.lastname: Reche
authors.forename: Javier A
authors.initials: JA
authors.lastname: Montero
authors.forename: Belen
authors.initials: B
authors.lastname: Pazos
authors.forename: Miguel A
authors.initials: MA
authors.lastname: Zapata
authors.forename: José C
authors.initials: JC
authors.lastname: Pastor
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000068258:Bevacizumab; D020256:Choroidal Neovascularization / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D005451:Fluorescein Angiography; D005500:Follow-Up Studies; D005584:Fovea Centralis / Q000473:pathology; D006801:Humans; D058449:Intravitreal Injections; D008875:Middle Aged; D047728:Myopia, Degenerative / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D010778:Photochemotherapy; D011446:Prospective Studies; D041623:Tomography, Optical Coherence; D016896:Treatment Outcome; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014792:Visual Acuity / Q000502:physiology
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab